NMT Medical To Release Fourth-Quarter And Year-End 2009 Financial Results On March 25

NMT Medical, Inc. (NASDAQ: NMTI) today announced that it will release its fourth-quarter and year-end 2009 financial results before the market opens on Thursday, March 25, 2010.

Management will host a conference call at 9:30 a.m. (ET) that morning to review the Company’s financial results and provide a business update. Individuals interested in listening to the live webcast of the conference call should log onto the “ Investors” section of NMT’s website, www.nmtmedical.com.

The call also may be accessed by dialing [phone] or [phone]. For interested individuals unable to join the live conference call, a webcast replay will be available on the Company’s website.

About NMT Medical, Inc.

NMT Medical is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. NMT is currently investigating the potential connection between a common heart defect that allows a right-to-left shunt or flow of blood through a defect like a patent foramen ovale (PFO) and brain attacks such as embolic stroke, transient ischemic attacks (TIAs) and migraine headaches. A common right-to-left shunt can allow venous blood, unfiltered and unmanaged by the lungs, to enter the arterial circulation of the brain, possibly triggering a cerebral event or brain attack. More than 32,000 PFOs have been treated globally with NMT's minimally invasive, catheter-based implant technology.

Stroke is the third leading cause of death in the United States and the leading cause of disability in adults. Each year, 750,000 Americans suffer a new or recurrent stroke and an additional 500,000 Americans experience a TIA.

For more information about NMT Medical, please visit www.nmtmedical.com.

>To order reprints of this article, click here: Reprints